Zhang Feng

W. M. Keck Career Development Professor of Biomedical Engineering

Institution
Massachusetts Institute of Technology

Country
US

Field
Biomedical Sciences

A pioneer in the sizzling new field of genome editing, Zhang has developed accurate and specific genome editing technology for application in eukaryotic cells—including human cells—from natural microbial CRISPR systems.

Awards have come aplenty, with the 2015 Robertson Stem Cell Prize, Cell’s “40 under 40” in 2014, and MIT Technology Review’s 10 Breakthrough Technologies in 2014. Before CRISPR, Zhang was also widely recognized for developing another breakthrough technology called optogenetics, in which neuronal activity can be controlled with light.

(Photo: Len Rubenstein/Broad Institute Communications)


Related articles

Scientists Provide A Crisp View Of ‘DNA Cutter’ Cas9

With an understanding of the detailed structure of Cas9, scientists hope to be able to design targeted gene-editing tools that can be used in humans and animals.

Healthy Aging, Happy Life: Lessons From China

Colette Browning, Professor of Healthy Aging at Monash University, writes about the Happy Life Club, a chronic illness management system that she is leading with colleagues at Peking University.